I am focusing on known pipeline that is the near-term focus for this company in billion dollar IMS markets with lots of competitors, some with ADF products, some with generics and all with branded.
We know very little about SunGen opportunities and give them little credence at this point. Elite still has to prove to the FDA that their technology works favorably. Lots of barking, but little bites so far.